Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cancer-cell-specific anti-transmembrane protein 180 antibody, anticancer drug, and cancer testing method

Cancer-cell-specific anti-transmembrane protein 180 antibody, anticancer drug, and cancer testing method

US Patent 10471146 · Granted Nov 12, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fusion protein suitable for dissolving fibrin clot, and pharmaceutical compositi2025
Fusion protein suitable for dissolving fibrin clot, and pharmaceutical compositi2025
Vehicle drive device2023
Anti-TMEM-180 antibody, anticancer drug and cancer testing method2023
Anti-TMEM-180 antibody, anticancer drug and cancer testing method2023
Anti-TMEM-180 antibody, anticancer drug and cancer testing method2023
Anti-TMEM-180 antibody, anticancer drug and cancer testing method2023
Cancer-cell-specific anti-TMEM-180 monoclonal antibody, anticancer drug, and can2022
Cancer-cell-specific anti-TMEM-180 monoclonal antibody, anticancer drug, and can2022
Cancer-cell-specific anti-TMEM-180 monoclonal antibody, anticancer drug, and can2022
Cancer-cell-specific anti-TMEM-180 monoclonal antibody, anticancer drug, and can2022
Antibody beneficial for treatment of solid tumors, antibody-drug conjugate, and 2022